Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Provided By GlobeNewswire
Last update: Feb 28, 2025
SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on February 24, 2025, the Board of Directors granted a non-qualified stock option award to purchase 56,000 shares of its common stock to two new non-executive employee under the Company’s Amended and Restated 2024 Inducement Equity Incentive Plan (the “2024 Inducement Plan”). The stock options were granted as an inducement material to the employee entering into employment with Skye in accordance with Nasdaq Listing Rule 5635(c)(4).
Read more at globenewswire.com1.51
-0.06 (-3.82%)
Find more stocks in the Stock Screener
SKYE Latest News and Analysis
8 days ago - ChartmillTop stock movements in today's session.Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
8 days ago - ChartmillTuesday's session: top gainers and losersIntrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
8 days ago - ChartmillThe market is filled with gapping stocks in Tuesday's session.In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
